CMPS — COMPASS Pathways Share News
0.000.00%
Last trade - 00:00Brief: Compass Pathways Commends White House Executive Order To Accelerate Research And Access For Psychedelic Treatments
Psychedelic drug developers rise after CBS report Trump backs more research
U.S. STOCKS ON THE MOVE-BlackRock, MDA Space, Revolution Medicines
U.S. STOCKS ON THE MOVE-Bloom, J&J, CarMax
U.S. STOCKS ON THE MOVE-Tesla, Nano-X, Travere
U.S. STOCKS ON THE MOVE-Bloom Energy, BlackRock, CoreWeave
Compass Pathways rises as it launches US training grants for psilocybin care
UK's Compass Pathways Q4 loss widens on warrant liability adjustment
Brief: Compass Pathways Announces Exercise Of $200 Million In Outstanding Warrants
Compass Pathways climbs premarket after $150 mln equity raise
Brief: Compass Pathways Announces Pricing Of $150 Million Public Offering
Compass Pathways extends rally after psychedelic depression treatment's late-stage study win
U.S. STOCKS ON THE MOVE-Ormat Technologies, Southwest Airlines, Jack Henry
Compass Pathways jumps as depression treatment study meets main goal
U.S. STOCKS ON THE MOVE-Ormat Technologies, Accenture, Kinsale Capital
U.S. STOCKS ON THE MOVE-Albemarle, Fiserv, ConocoPhillips
U.S. STOCKS ON THE MOVE-Norwegian Cruise Line, Paramount Skydance, Compass Pathways
Compass Pathways' depression treatment meets main goal in late‑stage study (updated)
Compass Pathways jumps as depression treatment study meets main goal